These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7534303

  • 1. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.
    Owen-Lynch PJ, Wong AK, Whetton AD.
    J Biol Chem; 1995 Mar 17; 270(11):5956-62. PubMed ID: 7534303
    [Abstract] [Full Text] [Related]

  • 2. Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line.
    Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD.
    J Cell Sci; 1995 Jul 17; 108 ( Pt 7)():2591-8. PubMed ID: 7593300
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
    Evans CA, Owen-Lynch PJ, Whetton AD, Dive C.
    Cancer Res; 1993 Apr 15; 53(8):1735-8. PubMed ID: 8467488
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, Toyama K.
    Exp Hematol; 1995 Oct 15; 23(11):1153-9. PubMed ID: 7556524
    [Abstract] [Full Text] [Related]

  • 9. Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
    Sanchez-Prieto R, Sanchez-Arevalo VJ, Servitja JM, Gutkind JS.
    Oncogene; 2002 Jan 31; 21(6):974-9. PubMed ID: 11840343
    [Abstract] [Full Text] [Related]

  • 10. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
    Raffel GD, Parmar K, Rosenberg N.
    J Biol Chem; 1996 Mar 01; 271(9):4640-5. PubMed ID: 8617726
    [Abstract] [Full Text] [Related]

  • 11. Rac is required for v-Abl tyrosine kinase to activate mitogenesis.
    Renshaw MW, Lea-Chou E, Wang JY.
    Curr Biol; 1996 Jan 01; 6(1):76-83. PubMed ID: 8805224
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
    Pearson MA, O'Farrell AM, Dexter TM, Whetton AD, Owen-Lynch PJ, Heyworth CM.
    Growth Factors; 1998 Jan 01; 15(4):293-306. PubMed ID: 9714913
    [Abstract] [Full Text] [Related]

  • 13. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation.
    Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, Saltiel AR.
    J Biol Chem; 1994 Feb 04; 269(5):3783-8. PubMed ID: 7508919
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony-stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase.
    Miyazawa K, Hendrie PC, Mantel C, Wood K, Ashman LK, Broxmeyer HE.
    Exp Hematol; 1991 Dec 04; 19(11):1110-23. PubMed ID: 1721591
    [Abstract] [Full Text] [Related]

  • 15. The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells.
    Gobert S, Duprez V, Lacombe C, Gisselbrecht S, Mayeux P.
    Eur J Biochem; 1995 Nov 15; 234(1):75-83. PubMed ID: 8529671
    [Abstract] [Full Text] [Related]

  • 16. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
    Hill RJ, Zozulya S, Lu YL, Hollenbach PW, Joyce-Shaikh B, Bogenberger J, Gishizky ML.
    Cell Growth Differ; 1996 Sep 15; 7(9):1125-34. PubMed ID: 8877093
    [Abstract] [Full Text] [Related]

  • 17. The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase.
    Chapman RS, Whetton AD, Dive C.
    Cancer Res; 1994 Oct 01; 54(19):5131-7. PubMed ID: 7923130
    [Abstract] [Full Text] [Related]

  • 18. Naturally occurring tyrosine kinase inserts block high affinity binding of phospholipase C gamma and Shc to TrkC and neurotrophin-3 signaling.
    Guiton M, Gunn-Moore FJ, Glass DJ, Geis DR, Yancopoulos GD, Tavaré JM.
    J Biol Chem; 1995 Sep 01; 270(35):20384-90. PubMed ID: 7657612
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.